Understanding pancreatic cancer through a systems metabolic approach
Systems Metabolic Approach for Multi-scale Pancreatic Cancer Phenotyping
This study is looking at pancreatic cancer by using different tests and methods to get a clearer picture of how the disease works, and it’s inviting patients to help by sharing samples or information that could lead to better treatments.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10946197 on NIH RePORTER |
What this research studies
This research investigates pancreatic cancer by integrating various diagnostic methods to better understand how the disease develops and spreads. It aims to combine insights from genetic mutations, imaging techniques, and tissue analysis to create a comprehensive picture of pancreatic cancer phenotypes. By linking measurements from different disciplines, the research seeks to identify consistent characteristics of the disease across multiple levels, which could lead to improved treatment strategies. Patients may be involved in providing samples or data that contribute to this integrative approach.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic adenocarcinoma or those at high risk for developing the disease.
Not a fit: Patients with non-cancerous pancreatic conditions or those who do not have pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and better outcomes for patients with pancreatic cancer.
How similar studies have performed: Other research has shown promise in integrating multi-modal approaches to cancer characterization, suggesting potential for success in this novel approach.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Jamshidi, Neema — University of California Los Angeles
- Study coordinator: Jamshidi, Neema
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.